|
International
|
National
|
Specialty
|
Pharma
|
Local
|
Total out of 11 registries (excluding locals)
|
Criteria requested
|
ISCRTN
|
CT
|
ACTR
|
UK NRR
|
PDQ
|
STD
|
RT†
|
R
|
GSK
|
N
|
CSR
| | |
Details not presented by registries
| | | | | | | | | | | |
x
| |
Details available
| | | | | | | | | | | | | |
Unique trial number
|
x
|
x
|
x
|
x
|
x
|
x
| |
x
| |
x
|
x
| |
9
|
Trial registration date
|
x
|
x
|
x
| | | | |
x
| | | | |
4
|
Secondary Ids
|
x
|
x
|
x
|
x
|
x
| | | | | |
x
| |
6
|
Funding source(s)
|
x
|
x
|
x
|
x
|
x
|
x
|
x
| |
x
|
x
|
x
| |
10
|
Primary sponsor
|
x
|
x
|
x
|
x
|
x
| |
x
|
x
| | |
x
| |
8
|
Secondary sponsor(s)
|
x
|
x
|
x
|
x
| | | |
X
| | |
x
| |
6
|
Responsible contact person
|
x
|
x
|
x
| | |
PNR
| |
x
| | | | |
5
|
Research contact person
|
x
|
x
|
x
|
x
|
x
|
x
|
x
| | | |
x
| |
8
|
Title of the study (brief title)
|
x
|
x
|
x
| |
x
|
x
| |
x
| |
x
|
x
| |
8
|
Official scientific title of the study
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
| |
x
| |
10
|
Research ethics review*
|
x
|
PNR
|
x
|
MC
|
PNR
| | | | | | | |
4
|
Countries of recruitment (replaced ethics review, May 2006)*
|
x
|
x
|
x
|
x
|
x
| | |
x
| | | | |
6
|
Condition
|
x
|
x
|
x
|
x
|
x
|
x
| |
x
|
x
|
x
|
x
| |
10
|
Intervention(s)
|
x
|
x
|
x
| |
x
|
x
| |
x
|
x
|
x
|
x
| |
9
|
Key inclusion and exclusion criteria
|
x
|
x
|
x
| |
x
|
x
| |
x
|
x
| |
x
| |
8
|
Study type
|
x
|
x
|
x
|
x
| |
x
| |
x
|
x
|
x
| | |
8
|
Anticipated trial start date
|
x
|
x
|
x
|
x
|
x
|
x
| |
x
|
x
| |
x
| |
9
|
Target sample size
|
x
|
x
|
x
| |
x
|
x
| | |
x
| |
x
| |
7
|
Recruitment status
|
x
|
x
|
x
| |
x
|
x
|
x
|
x
| | | | |
7
|
Primary outcome
|
x
|
x
|
x
|
x
|
x
|
x
| |
x
|
x
| |
x
| |
9
|
Key secondary outcomes
|
x
|
x
|
x
|
x
| |
x
| |
x
|
x
| | | |
7
|
Total out of 20 criteria
‡
|
20
|
20
|
20
|
13
|
16
|
14
|
5
|
16
|
10
|
6
|
14
| | |
Mentions WHO 2005/2006
|
x
|
x
|
x
|
x
|
-
|
x
|
-
|
-
|
-
|
-
|
-
| | |
Mentions ICJME 2004/2005
|
x
|
x
|
x
|
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
| | |